UBS Group’s Acadia Healthcare ACHC Stock Holding History

UBS Group’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,000	Closed	-$544K	–	9227
2023 Q4	$544K	Sell	7,000 -5,700	-45%	-$422K	﹤0.01%	5043
2023 Q3	$893K	Hold	12,700	–	–	﹤0.01%	4182
2023 Q2	$1.01M	Buy	12,700 +7,000	+123%	+$506K	﹤0.01%	4232
2023 Q1	$412K	Hold	5,700	–	–	﹤0.01%	4843
2022 Q4	$469K	Buy	+5,700	New	+$470K	﹤0.01%	4762
2015 Q1	–	Sell	-400	Closed	-$24K	–	8717
2014 Q4	$24K	Buy	+400	New	+$23.3K	﹤0.01%	7364

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

UBS Group's ACHC Position: Q2 2026 in Review

UBS Group increased its Acadia Healthcare (ACHC) stake by 43% in Q2 2026, buying an estimated $31.1M and bringing the position to 4,044,500 shares worth $119M. The position accounts for 0.02% of the portfolio, ranked #1002.

UBS Group first reported a position in ACHC in Q4 2014 and has held it in 47 quarters since. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

UBS Group held 4,044,500 shares of Acadia Healthcare worth $119M as of Q2 2026.
UBS Group bought 1,210,638 Acadia Healthcare shares in Q2 2026, an estimated $31.1M.
Acadia Healthcare made up 0.02% of UBS Group's portfolio in Q2 2026, its #1002 holding.
UBS Group first reported a position in Acadia Healthcare in Q4 2014 and has held it in 47 quarters since.
314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.